Pages

Nov 22, 2022

France, Germany, Spain agree on moving on with FCAS development



France, Germany and Spain have reached agreement over starting the next phase of the development of a new fighter jet dubbed FCAS, Europe's largest defence project at an estimated cost of more than 100 billion euros.

The three countries and their respective industries had struck a deal.

A French official also confirmed that the industries, seen as the main stumbling blocks on the way to an agreement recently, had found a deal to move to the next phase of the warplane project.

Previously, sources had said that the next development phase for the Future Combat Air System (FCAS) is expected to cost some 3.5 billion euros ($3.63 billion), to be shared equally by the three countries.

France's Dassault, Airbus and Indra - the latter two representing Germany and Spain, respectively - are involved in the scheme to start replacing French Rafale and German and Spanish Eurofighters from 2040.

French President Emmanuel Macron and then German Chancellor Angela Merkel first announced plans in July 2017 for FCAS, which will include a fighter jet and a range of associated weapons, including drones.

Lately, the project - originally meant to unify Europeans after the migration crisis and Britain's decision to leave the European Union - has been a source of tension between the two countries.

Last month, Macron cancelled a joint Franco-German ministerial meeting over disagreements with Berlin on a wide range of issues including defence and energy projects.

Both sides had been struggling for more than a year to agree the next stage of FCAS's development, although the French and German government broadly agreed on the project.

Some sources saw the blame lying with Dassault, as the company had refused to budge in a long-running row over intellectual property rights.

Other sources blamed Airbus for pushing for a bigger workshare of the Dassault-led project, insisting it should be given "equal footing" with the French company.

zawya

No comments:

Post a Comment